| 2.72 -0.03 (-1.09%) | 11-28 13:00 | |||||||||||||
|
|
| Short term | |
|||
| Mid term | |
|||
| Targets | 6-month : | 5.19 | 1-year : | 6.54 |
| Resists | First : | 4.44 | Second : | 5.59 |
| Pivot price | 2.82 |
|||
| Supports | First : | 2.57 | Second : | 2.14 |
| MAs | MA(5) : | 2.72 |
MA(20) : | 2.98 |
| MA(100) : | 5.2 |
MA(250) : | 7.82 |
|
| MACD | MACD : | -0.5 |
Signal : | -0.6 |
| %K %D | K(14,3) : | 19.3 |
D(3) : | 16.8 |
| RSI | RSI(14): 28.4 |
|||
| 52-week | High : | 15.53 | Low : | 2.57 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ OMI ] has closed above bottom band by 30.6%. Bollinger Bands are 69.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.8 - 2.81 | 2.81 - 2.82 |
| Low: | 2.68 - 2.7 | 2.7 - 2.71 |
| Close: | 2.73 - 2.75 | 2.75 - 2.77 |
Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. It operates through two segments, Global Solutions and Global Products. The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, which include supplier management, analytics, inventory management, and clinical supply management; and various programs to provide logistics and marketing solutions to its suppliers. The Global Products segment manufactures and sources medical surgical products for the prevention of healthcare-associated infections across the acute and alternate site channels. This segments products portfolio includes sterilization wraps, surgical drapes and gowns, facial protection products, protective apparel, medical exam gloves, custom and minor procedure kits, and other medical products. It provides its products and services to multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. The company was founded in 1882 and is headquartered in Richmond, Virginia.
Sun, 30 Nov 2025
Stark County top soccer, offensive football players. See who won the vote - Canton Repository
Sat, 29 Nov 2025
Candace Owens and Charlie Kirk controversy explained: Inside her statements on Erika Kirk, Emmanuel Macro - Times of India
Sat, 29 Nov 2025
Simone Biles Recalls ‘Random Weird Feeling’ on First Date With Jonathan Owens (Exclusive) - People.com
Fri, 28 Nov 2025
Simone Biles does split with a bottle of tequila after private jet trip for Bears' Black Friday game - New York Post
Fri, 28 Nov 2025
Obituary: John Russell Owens - Centralmaine.com
Thu, 27 Nov 2025
Candace Owens says Macrons ordered her killing, but there's no proof - Euronews.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 77 (M) |
| Shares Float | 61 (M) |
| Held by Insiders | 3.4 (%) |
| Held by Institutions | 97 (%) |
| Shares Short | 8,080 (K) |
| Shares Short P.Month | 7,800 (K) |
| EPS | -5.7 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -5.56 |
| Profit Margin | -12.5 % |
| Operating Margin | 8 % |
| Return on Assets (ttm) | 3.7 % |
| Return on Equity (ttm) | -196.4 % |
| Qtrly Rev. Growth | 1.5 % |
| Gross Profit (p.s.) | 28.95 |
| Sales Per Share | 139.23 |
| EBITDA (p.s.) | 6.54 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -99 (M) |
| Levered Free Cash Flow | 309 (M) |
| PE Ratio | -0.48 |
| PEG Ratio | 0 |
| Price to Book value | -0.49 |
| Price to Sales | 0.01 |
| Price to Cash Flow | -2.13 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |